A non-human primate model of Parkinson’s disease based on viral vector mediated overexpression of al

来源 :中国药理学会北美分会药理学学术大会 | 被引量 : 0次 | 上传用户:zhengji1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The present study aimed to develop a new non-human primate model of Parkinsons disease(PD)based on viral vector mediated overexpression of A53T alpha-synuclein(αSyn)to serve as a preclinical testing platform for evaluating potential therapeutics.
其他文献
Diabetes mellitus(DM) and stroke are leading causes of death and disability.Diabetes and hyperglycemia increase stroke risk significantly,therefore strict glycemic control is a top priority.
会议
To explore the pharmacy practice that clinical pharmacists carry out vancomycin individual treatment based on vancomycin population pharmacokinetics and therapeutic drug monitoring in order to expand
The exposure to genotoxic chemicals and the occurrence of reactive electrophiles formed in endogenous cellular processes can induce chemical modifications of DNA(DNA adducts or adductomics)and thus tr
Structures of G-protein coupled receptors are mostly determined by protein X-ray crystallography.Most such receptors need important stabilization efforts either by using stabilizing protein inserts an
会议
Transverse tubule(TT)networks are critical structures for excitation contraction coupling in striated muscles.Mitsugumin 29(MG29)is a muscle-specific member of the synaptophysin family protein that pa
Anaphylactoid Purpura/Henoch-Schonlein Purpura(HSP),the most usual systematic disease in childhood,is a systemic vasculitis with the small vessel vasculitis as the main pathological change.In clinical
This study aimed to observe the effects of tetramethylpyrazine on the regeneration of cochlear hair cells exposed to gentamicin by auditory brainstem response test under scanning electron microscope.
Genetic variants in the pharmacokinetic(PK)mechanism are the main underlying factors affecting the anti-platelet response to clopidogrel.
All existing antipsychotic medications target the dopamine D2 receptor,but many patients with schizophrenia do not respond to these treatments.
会议
Non-human primate models of Parkinsons disease(PD)have had a tremendous impact on the drug development process over the past 30 years.In particular,monkeys administered MPTP have provided models of ad